MARCUZZI, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 2.928
EU - Europa 690
AS - Asia 243
AF - Africa 4
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.869
Nazione #
US - Stati Uniti d'America 2.926
PL - Polonia 442
CN - Cina 198
IT - Italia 93
GB - Regno Unito 46
UA - Ucraina 31
FR - Francia 23
VN - Vietnam 21
DE - Germania 17
TR - Turchia 15
RU - Federazione Russa 13
FI - Finlandia 9
IE - Irlanda 5
HK - Hong Kong 4
SE - Svezia 4
BE - Belgio 2
BR - Brasile 2
CA - Canada 2
NL - Olanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
DZ - Algeria 1
ES - Italia 1
JP - Giappone 1
KE - Kenya 1
KR - Corea 1
MA - Marocco 1
MD - Moldavia 1
PK - Pakistan 1
RO - Romania 1
SG - Singapore 1
TH - Thailandia 1
TN - Tunisia 1
Totale 3.869
Città #
Fairfield 669
Warsaw 442
Woodbridge 350
Ashburn 281
Seattle 266
Houston 244
Cambridge 235
Wilmington 196
Beijing 88
Ann Arbor 85
Princeton 71
Chandler 59
San Diego 46
Jacksonville 34
Shanghai 26
Ferrara 21
London 21
Dong Ket 20
Nanjing 17
Jinan 15
Aprilia 12
Izmir 12
Los Angeles 12
New York 12
Falls Church 10
Boardman 9
Changsha 9
Redwood City 9
Shenyang 9
Norwalk 8
Hebei 7
Mountain View 7
Bologna 6
Hounslow 6
Milan 6
Nanchang 6
Dublin 5
Lanzhou 5
Azzano Decimo 4
Chicago 4
Hong Kong 4
Moscow 4
Saint Petersburg 4
Trieste 4
Bentivoglio 3
Chiswick 3
Dearborn 3
Ferrara di Monte Baldo 3
Gorizia 3
Redmond 3
Taizhou 3
Tianjin 3
Addison 2
Bremen 2
Brussels 2
Des Moines 2
Fuzhou 2
Kilburn 2
Naples 2
Ningbo 2
Rome 2
Southwark 2
Spinea 2
São Paulo 2
Verona 2
Zhengzhou 2
Amsterdam 1
Auburn Hills 1
Bedford 1
Burlington 1
Casablanca 1
Caserta 1
Chieri 1
Chisinau 1
Edison 1
Frankfurt am Main 1
Guangzhou 1
Hangzhou 1
Helsinki 1
Hemel Hempstead 1
Hung Yen 1
Karachi 1
Kent 1
Krimpen Aan Den Ijssel 1
Kunming 1
Lappeenranta 1
Leawood 1
Montreal 1
Mulhouse 1
Munich 1
Nairobi 1
Orange 1
Phoenix 1
Prescot 1
Ruda 1
Santa Clara 1
Santa Cruz 1
Taiyuan 1
Tappahannock 1
Toronto 1
Totale 3.446
Nome #
Neuronal dysfunction associated with cholesterol deregulation 205
Cytokine levels in the serum of healthy subjects 159
Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children 136
Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17 135
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 123
Two-gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results 123
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 122
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 111
Type I interferon-mediated autoinflammation due to DNase II deficiency 111
Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration 93
To extinguish the fire from outside the cell or to shutdown the gas valve inside? Novel trends in anti-inflammatory therapies 91
TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide 89
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency 87
Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage 86
Putative modifier genes in mevalonate kinase deficiency 81
Repositioning of Tak-475 in mevalonate kinase disease: Translating theory into practice 78
Alendronate, a double-edged sword acting in the mevalonate pathway 72
Innovative target therapies are able to block the inflammation associated with dysfunction of the cholesterol biosynthesis pathway 70
Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? 69
Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry 68
Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011) 65
Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency 62
Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease 61
Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes 60
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line 55
A common genetic background could explain early-onset Crohn's disease 54
Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line 54
Role of vitamin D in the pathogenesis of atheromatosis 54
The effect of clodronate on a mevalonate kinase deficiency cellular model 53
Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets 52
Clinical Genetic Testing of Periodic Fever Syndromes 51
Comments to the editor concerning the paper entitled "Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways" Shiekh Tanveer Ahmad et al 51
Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency 51
A comparative analysis of serologic parameters and oxidative stress in osteoarthritis and rheumatoid arthritis: reply to Mishra and colleagues 51
Presence of IL-9 in paired samples of human colostrum and transitional milk 51
Block of the Mevalonate Pathway Triggers Oxidative and Inflammatory Molecular Mechanisms Modulated by Exogenous Isoprenoid Compounds 50
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis 50
Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes 50
Database tools in genetic diseases research 49
Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype 48
Curcumin and inflammatory bowel disease: Potential andlimits of innovative treatments 47
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes 45
Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis 43
Mevalonate kinase deficiency and IBD: shared genetic background 42
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders 42
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches 41
Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients 41
Serum amyloid A and cholesterol: a pivotal role on inflammation 41
Letter: inflammatory bowel disease, complementary and alternative medicine, and genetics 40
Inflammation profile of four early onset Crohn patients 38
Farnesyl and geranylgeranyl transferase inhibitors: an anti-inflammatory effect. Comment to "Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells" Haematologica. 2013;98(1):31-40 38
Evolutionary hypothesis of the Mevalonate Kinase Deficiency 36
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study 29
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 29
Lysozyme-containing chitosan-coated arginate microspheres for oral immunisation 25
Mouse model of mevalonate kinase deficiency: comparison of cytokines and chemokines profile with human patients 24
Mevalonate kinase deficiency: Disclosing the role of mevalonate pathway modulation in inflammation 23
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 21
New Mechanisms in Autoinflammatory Diseases 20
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 18
MitoQ is able to modulate apoptosis and inflammation 16
Clarification of the pleiotropic effects of statins on mevalonate pathway and the feedback regulation of isoprenoids requires more comprehensive investigation 16
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 14
Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency 13
Long non-coding RNA GAS5 and intestinal MMP2 and MMP9 expression: A translational study in pediatric patients with IBD 13
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 13
Systemic and neuronal inflammatory markers in a mouse model of mevalonate kinase deficiency: a strain-comparative study 12
Post-irradiation hyperamylasemia is a prognostic marker for allogeneic hematopoietic stem cell transplantation outcomes in pediatric population: A retrospective single-centre cohort analysis 10
Family history in early-onset inflammatory bowel disease 9
Microcapsule a doppio strato di polisaccaridiutilizzabili come veicoli per la somministrazione oraledi sostanze biologicamente attive 9
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 7
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 6
Standard treatment–refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus-specific hyperimmune globulin 6
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 5
Editorial: Advances in stem cell therapy: new applications and innovative therapeutic approaches 3
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study 3
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 3
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions 1
Totale 4.023
Categoria #
all - tutte 23.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019111 0 0 0 0 0 0 0 0 0 0 50 61
2019/20201.524 42 20 16 43 52 230 254 228 258 188 114 79
2020/20211.227 46 123 70 104 138 154 96 138 53 199 40 66
2021/2022470 35 36 15 12 11 47 36 40 20 70 21 127
2022/2023303 79 9 19 14 15 24 14 17 46 4 43 19
2023/2024237 33 36 28 9 31 22 20 22 16 20 0 0
Totale 4.023